Fujirebio Europe (previously Innogenetics), a leading international healthcare company that conceives, develops, produces and markets high quality in vitro diagnostics (IVD) testing solutions worldwide, will be showcasing its LUMIPULSE® G1200, a fully automated chemiluminescent enzyme immunoassay (CLEIA) system, at the 58th edition of the Journées Internationales de Biologie (JIB) in the CNIT Paris la Défense, France, from November 13 to 15. The LUMIPULSE® G1200 will be presented at the Fujirebio Europe booth number D61 during all 3 days of the congress.